Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 1, 1997, Pages 75-83

  Li, Jin S ^a   Sharifi, Ali M ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Antihypertensive therapy; Blood vessels; Endothelium; Hypertension; Hypertrophy; Losartan; Remodeling; Resistance arteries

Indexed keywords

ANGIOTENSIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BIPHENYL DERIVATIVE; IMIDAZOLE DERIVATIVE; RENIN; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; AORTA; ARTERY; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DRUG ANTAGONISM; DRUG EFFECT; FEMORAL ARTERY; HEART; HYPERTROPHY; MESENTERIC ARTERY; MUSCLE CONTRACTION; MYOGRAPHY; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PRESSURE; RENAL ARTERY; VASCULAR SMOOTH MUSCLE; WISTAR KYOTO RAT;

ANIMALS; AORTA; ARTERIES; BIPHENYL COMPOUNDS; BLOOD PRESSURE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMORAL ARTERY; HEART; HYPERTROPHY; IMIDAZOLES; LOSARTAN; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; ORGAN SIZE; PRESSURE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENAL ARTERY; RENIN; TETRAZOLES;

EID: 0030612267     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199707000-00011     Document Type: Article

References (43)

1. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and in increased number of smooth muscle cell layers. Circ Res 1978;43:854-64.
2. Mulvany MJ, Korsgaard N. Correlations and otherwise between blood pressure, cardiac mass and resistance vessel characteristics in hypertensive, normotensive and hypertensive/normotensive hybrid rats. J Hypertens 1983;1:235-44.
3. Mulvany MJ, Baandrup U, Gundersen HJG. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a 3-dimensional dissector. Circ Res 1985;57: 794-800.
4. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968-72.
5. Deng LY, Schiffrin EL. Effects of endothelin-1 and vasopressin on small arteries of spontaneously hypertensive rats. Am J Hypertens 1992;5:817-22.
6. Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens 1995;13:1546-59.
7. Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 1993;30:73-9.
8. Izzard AS, Heagerty AM. Hypertension and the vasculature: arterioles and the myogenic response. J Hypertens 1995;13:1-4.
9. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens 1989;7:83-90.
10. Mulvany MJ, Persson AEG, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991;9:589-93.
11. Brush JE, Cannon RO, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-7.
12. Harrap SB, Van der Merwe WM, Griffin SA, McPherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990;16:603-14.
13. Lee RMKW, Berecek KH, Tsoporis J, McKenzie R, Triggle CR. Prevention of hypertension and vascular changes by captopril treatment. Hypertension 1991;17:141-50.
14. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23:659-66.
15. Li J-S, Schiftrin EL. Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J Cardiovasc Pharmacol 1996;28:68-74.
16. Morton JJ, Beattie EC, MacPherson F. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vasc Res 1992;29:264-9.
17. Shaw LM, George PR, Oldham AA, Heagerty AM. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries. J Hypertens 1995;13:1135-43.
18. Li J-S, Schiffrin EL. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 1995;25(Part 1):495-500.
19. Falloon BJ, Bund SJ, Tulip JR, Heagerty AM. In vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension 1993;22:486-95.
20. Falloon BJ, Stephens N, Tulip JR, Heagerty AM. Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol 1995;268:H670-8.
21. Schiffrin EL. Vascular structure in L-NAME-induced hypertension: methodological considerations for studies of small arteries in hypertension. J Hypertens 1995;13:817-21.
22. Li J-S, Schiffrin EL. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J Hypertens 1995;13:647-52.
23. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Hypertension 1994;24:183-8.
24. Deng LY, Schiffrin EL. Effects of endothelin on small arteries of DOCA-salt hypertensive rats. Am J Physiol 1992;262:H1782-7.
25. Deng LY, Li J-S, Schiffrin EL. Endothelium-dependent relaxation in small arteries from essential hypertensive patients: comparison with spontaneously hypertensive rats. Clin Sci 1995;88:611-22.
26. Touyz RM, Deng LY, Schiffrin EL. Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. Hypertension 1995;26(Part 2):1041-5.
27. Hajdu MA, Baumbach GL. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol 1994;266:H1027-33.
28. Schiffrin EL, Larivière R, Li J-S, Sventek P. Enhanced expression of endothelin-1 gene in DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 1996;33:235-48.
29. Diedrich DA, Yang Z, Bühler FR, Lüscher TF. Impaired endothelium-dependent relaxations in hypertensive small arteries involve the cyclooxygenase pathway. Am J Physiol 1990;258:H445-51.
30. Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension 1991;17:626-35.
31. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia: autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
32. Clozel J-P, Kuhn H, Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens 1989;7:267-75.
33. Schiffrin EL, Deng LY. Comparison of effects of angiotensin I-converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients. Hypertension 1995;25(Part 2):699-703.
34. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23:83-91.
35. 1 subtype receptors in the rat carotid artery. Arterioscl Thromb Vasc Biol 1995;15:1646-51.
36. 2 production in conscious rats. J Clin Invest 1996;97:1978-82.
37. Hajdu MA, Heistad DD, Baumbach GL. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991;17:308-16.
38. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25(Part 1):474-81.
39. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: comparison with effects of a beta blocker. Am J Hypertens 1995;8:229-36.
40. Dunn WR, Gardiner SM. No evidence for vascular remodeling during hypertension induced by chronic inhibition of nitric oxide synthase in Brattleboro rats. J Hypertens 1995;13:849-57.
41. Lew JM, Angus JA. Wall thickness to lumen diameter ratios of arteries from SHR and WKY: comparison of pressurised and wire-mounted preparations. J Vasc Res 1992;29:435-42.
42. Heagerty AM, Izzard AS. Small-artery changes in hypertension. J Hypertens 1995;13:1560-5.
43. Buus NH, VanBavel E, Mulvany MJ. Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations. Br J Pharmacol 1994;112:579-87.